| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KALA BIO, Inc. | Director | Common Stock | 10.2K | $35.6K | $3.48 | Jun 15, 2025 | Direct |
| KALA BIO, Inc. | Director | Stock Option (right to buy) | 5.45K | Jun 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Jun 15, 2025 | 2 | $0 | 4 | Jun 17, 2025 | Director |
| KALA | KALA BIO, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Jun 22, 2023 | 4 | $0 | 4 | Jun 23, 2023 | Director |
| KALA | Kala Pharmaceuticals, Inc. | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Oct 31, 2022 | 1 | $0 | 4 | Nov 1, 2022 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Oct 31, 2022 | 0 | $0 | 3 | Nov 1, 2022 | Director |